Ruchi Mallya

Ruchi Mallya has extensive experience in forecasting and commercial data analytics within the biotechnology and pharmaceutical sectors. Currently employed at ADC Therapeutics since September 2020, Ruchi has previously held positions at Aquestive Therapeutics, Immunomedics, Pacira Pharmaceuticals, and Aptalis Pharma, focusing on commercial operations, analytics, and business forecasting. Ruchi began the career at Hoffmann-La Roche as a research scientist and later worked as an associate engineer at Con Edison. Ruchi holds a Master’s degree in Biomedical Engineering from Columbia Engineering and a Bachelor's degree in Chemical Engineering from The Cooper Union for the Advancement of Science and Art.